Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 45,917 | 316,581 | 139,311 | 5,508 | 27,643 |
| Gross Profit | 45,917 | 316,581 | 139,311 | 5,508 | 27,643 |
| Operating Expenses | 54,313 | 91,631 | 57,843 | 33,604 | 34,676 |
| Operating Income | -8,396 | 224,950 | 81,468 | -28,096 | -7,033 |
| Other Income | 1,510 | 5,859 | 3,239 | 3,124 | 4,960 |
| Pre-tax Income | -6,886 | 230,809 | 84,707 | -24,972 | -2,073 |
| Income Tax | -101 | 62,236 | 24,761 | -3,592 | 250 |
| Net Income Continuous | -6,785 | 168,573 | 59,946 | -21,380 | -2,323 |
| Net Income | $-6,785 | $168,573 | $59,946 | $-21,380 | $-2,323 |
| EPS Basic Total Ops | -0.02 | 0.59 | 0.22 | -0.08 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | 0.59 | 0.21 | -0.08 | -0.01 |
| EPS Diluted Total Ops | -0.02 | 0.54 | 0.20 | -0.08 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | 0.54 | 0.20 | -0.08 | -0.01 |
| EBITDA(a) | $-2,355 | $229,923 | $88,226 | $-25,785 | $-2,818 |